Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

15.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Cancer Therapies02:49

Cancer Therapies

8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Meloxicam-1-d-MT Dual-Drug Hydrogel Serves as an Immunomodulator to Reverse Tumor Postoperative Recurrence and Metastasis.

ACS applied materials & interfaces·2026
Same author

A Self-Assembled Irinotecan Nanomedicine Abrogates Steatohepatitis-Induced Liver Metastasis and Potentiates Antitumor Efficacy against Colorectal Cancer.

ACS nano·2026
Same author

Manganese-engineered Lactobacillus Reuteri with enhanced antitumor and immunomodulatory activities for colorectal cancer prevention and treatment.

Nature communications·2025
Same author

Correction to "Sericin Nerve Guidance Conduit Delivering Therapeutically Repurposed Clobetasol for Functional and Structural Regeneration of Transected Peripheral Nerves".

ACS biomaterials science & engineering·2025
Same author

Engineering of a Mantis-Forelimb-Inspired Bioabsorbable Lens-like Ocular Therapeutic (BLOT) Device for Effective Bacterial Keratitis Treatment.

Nano letters·2025
Same author

Bioactive Silk Sericin/Bioceramic Nerve Guidance Conduit for Effective Repair of Long-Gap Transected Peripheral Nerve Injury through Regulating Schwann Cells.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

Video Experimental Relacionado

Updated: Oct 2, 2025

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks
04:53

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks

Published on: May 26, 2023

1.3K

El marco orgánico metálico basado en cobre supera la quimiorresistencia del cáncer al interrumpir sistemáticamente la

Jia Liu1, Ye Yuan1,2, Yanni Cheng1

  • 1Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Journal of the American Chemical Society
|February 22, 2022
PubMed
Resumen

Un nuevo marco orgánico metálico basado en cobre (CuHPT) ataca las células cancerosas resistentes a los medicamentos al interrumpir su homeostasis redox, induciendo estrés oxidativo y matando selectivamente a las células cancerosas. Este enfoque muestra un potencial significativo en los modelos preclínicos para superar la quimiorresistencia.

Más Videos Relacionados

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

601
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

58.0K

Videos de Experimentos Relacionados

Last Updated: Oct 2, 2025

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks
04:53

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks

Published on: May 26, 2023

1.3K
Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

601
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

58.0K

Área de la Ciencia:

  • Ingeniería biomédica
  • Ciencias de los materiales
  • En el campo de la oncología

Sus antecedentes:

  • La resistencia a los fármacos es un factor primario de la recurrencia del cáncer, a menudo exacerbado por mecanismos celulares complejos.
  • Las terapias convencionales con frecuencia fallan contra los cánceres resistentes, a veces incluso promoviendo la resistencia a través de vías alternativas.

Objetivo del estudio:

  • Diseñar un nuevo agente terapéutico dirigido a las vulnerabilidades bioquímicas únicas de las células cancerosas resistentes a los medicamentos.
  • Investigar el potencial de un marco metálico-orgánico basado en cobre (CuHPT) para superar la resistencia a los medicamentos químicos.

Principales métodos:

  • Desarrollo de un marco metálico orgánico basado en cobre/catecol (CuHPT) de tamaño nanométrico.
  • Investigación del mecanismo de desmontaje de CuHPT dentro de las células cancerosas, desencadenado por el glutatión (GSH).
  • Evaluación de la capacidad de CuHPT para inducir estrés oxidativo a través de la generación de ROS y el agotamiento de GSH.
  • Evaluación de la citotoxicidad de CuHPT contra las células cancerosas resistentes a los fármacos in vitro e in vivo.

Principales resultados:

  • El CuHPT se desmonta selectivamente en las células resistentes a los fármacos, liberando iones de cobre y ligandos de catecol.
  • El desmontaje amplifica la producción de especies reactivas de oxígeno (ROS) intracelulares al agotar la GSH, lo que lleva al estrés oxidativo.
  • El CuHPT demostró una citotoxicidad potente y selectiva contra múltiples líneas de células cancerosas resistentes a los fármacos.
  • Los estudios in vivo mostraron que el CuHPT inhibió eficazmente el crecimiento tumoral y mejoró significativamente las tasas de supervivencia en ratones.

Conclusiones:

  • El CuHPT actúa como un terapéutico inteligente al deconstruir con precisión la homeostasis redox de las células cancerosas resistentes a los medicamentos.
  • Este nuevo MOF a base de cobre ofrece una estrategia prometedora para superar la quimiorresistencia y mejorar los resultados del tratamiento del cáncer.